MeTA Kenya

Origins of MeTA

The Medicines Transparency Alliance (MeTA) began as a hypothesis, which evolved into a policy and later a project.  In 2008, the United Kingdom’s Department for International Development (DFID) turned this hypothesis into policy.  This was in part, as a response to the United Nation’s Millennium Development Goals (MDGs) and MDG 8 in particular.  With the support of the World Bank (WB) and the World Health Organization (WHO), DFID invited seven countries to run this ambitious pilot.  These countries were: Ghana, Jordan, Kyrgyzstan, Peru, the Philippines, Uganda and Zambia.  This project run between 2008 to 2015 in collaboration with Health Action International and it sought to test the hypothesis that increasing transparency and accountability in the pharmaceutical sector would improve access to medicines by improving decision-making. (  Kenya are the new entrants in the MeTA initiative together with  Tanzania, while remaining active in Ghana, Zambia and Uganda.

How MeTA works:

The Medicines Transparency Alliance Medicines Transparency Alliance (MeTA) brings together all stakeholders in the medicines market to improve access, availability and affordability of medicines and in this instance with specific focus on sexual reproductive health rights (SRHR) and commodities.

The primary stakeholders in this alliance are the government, the civil society, development partners, counties and private sector who through an established dialogue and dissent space work to ensure greater responsibility and accountability with the intention of increasing access to sexual reproductive health commodities to the most vulnerable sectors of society.

The MeTA approach emphasizes on dialogue and collective learning to improve innovation, decision making and action while overcoming conflict and promoting constructive engagement.

MeTA Kenya

MeTA Kenya council members have representation from the Ministry of Health, KEMSA, Health CSOs network,  development partners of health, Counties, Development agencies, private sector among others. MeTA Kenya facilitates round table discussions between multi-stakeholders to generate innovative solutions to the tough problems of supplying the right medicines to poor people, at the right price, of the right quality, in a timely and accessible manner by:

  • Identifying and spearheading advocacy initiatives to increase access to SRHC & support the improvement of RMNCAH outcomes in the partnership with RMHSU of MoH
  • Supporting learning and dissemination events (MeTA Forum)
  • Supporting dissemination of key IEC materials for RMHSU
  • Dissemination of key knowledge products from the annual SRHC studies